Oral sexual behaviors associated with prevalent oral human papillomavirus infection.

PubWeight™: 5.24‹?› | Rank: Top 1%

🔗 View Article (PMID 19320589)

Published in J Infect Dis on May 01, 2009

Authors

Gypsyamber D'Souza1, Yuri Agrawal, Jane Halpern, Sacared Bodison, Maura L Gillison

Author Affiliations

1: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles citing this

(truncated to the top 100)

HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol (2010) 6.53

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70

p16 positive oropharyngeal squamous cell carcinoma:an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol (2010) 3.37

Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet (2013) 3.25

The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev (2010) 1.94

Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88

Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis (2010) 1.85

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65

Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis (2012) 1.48

Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol (2009) 1.45

Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis. BMJ (2015) 1.43

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41

The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med (2011) 1.40

Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study). Cancer Epidemiol Biomarkers Prev (2011) 1.37

Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol (2012) 1.29

Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One (2012) 1.28

Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men. BMC Infect Dis (2011) 1.23

Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J (2010) 1.22

Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol (2014) 1.19

Koilocytes indicate a role for human papilloma virus in breast cancer. Br J Cancer (2009) 1.18

The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas. Oral Oncol (2013) 1.17

Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck (2010) 1.16

Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners. J Clin Oncol (2014) 1.16

Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One (2013) 1.14

A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer (2012) 1.11

Discussing the diagnosis of HPV-OSCC: common questions and answers. Oral Oncol (2013) 1.09

Epidemiology of oral human papillomavirus infection. Oral Oncol (2013) 1.07

New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital (2013) 1.07

Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review). Int J Oncol (2014) 1.06

Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol (2011) 1.01

Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Curr Opin Oncol (2013) 1.01

Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci (2014) 0.98

High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health (2011) 0.98

Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005. PLoS One (2012) 0.97

Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys (2014) 0.97

Prevalence and risk factors for oral HPV infection in young Australians. PLoS One (2014) 0.96

Human papillomavirus, smoking, and head and neck cancer. Am J Otolaryngol (2011) 0.95

The relationship between oral squamous cell carcinoma and human papillomavirus: a meta-analysis of a Chinese population (1994-2011). PLoS One (2012) 0.94

Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.94

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma. Cancer (2012) 0.94

Cancer of unknown primary originating from oropharyngeal carcinomas are strongly correlated to HPV positivity. Virchows Arch (2012) 0.92

Prospects for prevention of HPV-driven oropharynx cancer. Oral Oncol (2013) 0.92

Smoking increases oral HPV persistence among men: 7-year follow-up study. Eur J Clin Microbiol Infect Dis (2013) 0.91

The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer. Biologics (2010) 0.91

Oral cancer, HPV infection and evidence of sexual transmission. Med Oral Patol Oral Cir Bucal (2013) 0.90

Human papillomaviruses as therapeutic targets in human cancer. J Clin Oncol (2011) 0.90

Improved survival with HPV among African Americans with oropharyngeal cancer. Clin Cancer Res (2013) 0.90

A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide. Oncologist (2013) 0.89

Lessons learned from next-generation sequencing in head and neck cancer. Head Neck (2012) 0.88

Six-month incidence and persistence of oral HPV infection in HIV-negative and HIV-infected men who have sex with men. PLoS One (2014) 0.88

Viruses and breast cancer. Cancers (Basel) (2010) 0.87

Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines. Klin Padiatr (2012) 0.86

Human papillomavirus and tonsillar and base of tongue cancer. Viruses (2015) 0.86

Virology and molecular pathogenesis of HPV (human papillomavirus)-associated oropharyngeal squamous cell carcinoma. Biochem J (2012) 0.86

Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer (2010) 0.86

Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities. J Public Health Res (2014) 0.86

An update on oral human papillomavirus infection. Indian J Sex Transm Dis (2013) 0.85

HPV-associated Oropharyngeal Cancers--Are They Preventable? Cancer Prev Res (Phila) (2011) 0.85

Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol (2012) 0.85

Sensitive HPV detection in oropharyngeal cancers. BMC Cancer (2009) 0.85

Prevalence, genotype distribution and persistence of human papillomavirus in oral mucosa of women: a six-year follow-up study. PLoS One (2012) 0.84

Oral HPV infection and sexuality: a cross-sectional study in women. Int J Mol Sci (2011) 0.84

Oral human papillomavirus is common in individuals with Fanconi anemia. Cancer Epidemiol Biomarkers Prev (2015) 0.83

Kissing: hullo hpv. Curr Oncol (2011) 0.83

Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol (2015) 0.83

Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities. Head Neck (2011) 0.83

Clinical and scientific impact of human papillomavirus on head and neck cancer. World J Clin Oncol (2014) 0.83

Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review. World J Clin Cases (2014) 0.83

Oral Human Papillomavirus (HPV) Infection among Unvaccinated High-Risk Young Adults. Cancers (Basel) (2014) 0.83

Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature. Indian J Dent (2015) 0.83

Determinants of prevalent human papillomavirus in recently formed heterosexual partnerships: a dyadic-level analysis. J Infect Dis (2014) 0.82

Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma. Sci Rep (2015) 0.82

Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.82

Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma. Cancer Prev Res (Phila) (2014) 0.82

Biologic predictors of serologic responses to HPV in oropharyngeal cancer: The HOTSPOT study. Oral Oncol (2015) 0.82

HPV and cancer of the oral cavity. Virulence (2015) 0.82

Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp. BMC Infect Dis (2014) 0.81

Human papilloma virus infection in head and neck cancer. Dtsch Arztebl Int (2013) 0.81

The role of sexual behavior in head and neck cancer: implications for prevention and therapy. Expert Rev Anticancer Ther (2014) 0.81

Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Adolesc Health Med Ther (2011) 0.80

Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects. Wien Med Wochenschr (2010) 0.80

Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. Head Neck (2016) 0.80

Joint disease mapping of cervical and male oropharyngeal cancer incidence in blacks and whites in South Carolina. Spat Spatiotemporal Epidemiol (2010) 0.80

Exploring the implications of HPV infection for head and neck cancer. Sex Transm Infect (2015) 0.79

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer. Viruses (2015) 0.79

Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China. PLoS One (2015) 0.79

Human papillomavirus induced transformation in cervical and head and neck cancers. Cancers (Basel) (2014) 0.79

Screening and detection of human papillomavirus (HPV) high-risk strains HPV16 and HPV18 in saliva samples from subjects under 18 years old in Nevada: a pilot study. BMC Oral Health (2012) 0.79

Genome stability pathways in head and neck cancers. Int J Genomics (2013) 0.79

Oral environment and cancer. Genes Environ (2016) 0.79

Role of viruses in oral squamous cell carcinoma. Oncol Rev (2012) 0.79

Previous tonsillectomy modifies odds of tonsil and base of tongue cancer. Br J Cancer (2016) 0.79

Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. Otolaryngol Clin North Am (2012) 0.78

Oral sexual behaviors and the prevalence of oral human papillomavirus infection. J Infect Dis (2009) 0.78

Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis. J Clin Med Res (2016) 0.78

Personal and social influences regarding oral sex among African American female adolescents. J Womens Health (Larchmt) (2011) 0.78

Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy. PLoS One (2017) 0.78

The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis (2015) 0.77

Articles cited by this

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA (2006) 7.46

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42

Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst (2004) 3.43

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 3.04

Oral sex and the transmission of viral STIs. Sex Transm Infect (1998) 2.50

Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37

Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (2005) 1.97

Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J (2007) 1.88

Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J Clin Microbiol (2005) 1.81

Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr (2005) 1.51

Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect (2000) 1.35

Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis (2007) 1.34

Articles by these authors

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80

Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res (2003) 3.42

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis (2004) 3.04

Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol (2013) 3.00

Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol (2006) 2.91

Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial. Lancet (2008) 2.79

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer (2008) 2.67

Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck (2009) 2.59

Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res (2009) 2.51

Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37

A novel role for otolaryngologists in the multidisciplinary Difficult Airway Response Team. Laryngoscope (2014) 2.00

Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol (2012) 1.96

Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88

Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma. Clin Cancer Res (2008) 1.85

Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol (2012) 1.81

Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev (2011) 1.68

Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr (2006) 1.66

Head and neck cancers. J Natl Compr Canc Netw (2011) 1.64

Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst (2011) 1.59

Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res (2002) 1.53

The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis (2012) 1.51

Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res (2007) 1.48

Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res (2013) 1.47

A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Am J Trop Med Hyg (2006) 1.46

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2014) 1.39

Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37

Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis (2004) 1.36

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.35

Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2002) 1.30

Human papillomavirus in HNSCC: recognition of a distinct disease type. Hematol Oncol Clin North Am (2008) 1.28

Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) (2011) 1.27

Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol (2006) 1.18

Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine (2006) 1.16

Automated high throughput DNA isolation for detection of human papillomavirus in oral rinse samples. J Clin Virol (2011) 1.14

No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer (2010) 1.06

Prevalence and impact of bilateral vestibular hypofunction: results from the 2008 US National Health Interview Survey. JAMA Otolaryngol Head Neck Surg (2013) 1.02

Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02

The fanconi anemia pathway limits human papillomavirus replication. J Virol (2012) 1.01

Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit Rev Oral Biol Med (2003) 1.01

Early adaptation and compensation of clinical vestibular responses after unilateral vestibular deafferentation surgery. Otol Neurotol (2014) 1.00

Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99

Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol (2009) 0.97

Hearing outcomes after surgical plugging of the superior semicircular canal by a middle cranial fossa approach. Otol Neurotol (2012) 0.97

A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst (2003) 0.96

Suprabasin is hypomethylated and associated with metastasis in salivary adenoid cystic carcinoma. PLoS One (2012) 0.96

Epidemiology of vestibulo-ocular reflex function: data from the Baltimore Longitudinal Study of Aging. Otol Neurotol (2015) 0.96

Elective versus Therapeutic Neck Dissection in Oral Cancer. N Engl J Med (2015) 0.92

Visual impairment, uncorrected refractive error, and objectively measured balance in the United States. JAMA Ophthalmol (2013) 0.91

Mucosal melanoma of the head and neck. J Natl Compr Canc Netw (2012) 0.89

The Annex C fallacy: why unscreened databases are usually preferable for comparison of industrially exposed groups. Audiol Neurootol (2010) 0.89

Clinical testing of otolith function: perceptual thresholds and myogenic potentials. J Assoc Res Otolaryngol (2013) 0.89

A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection. Sex Transm Dis (2015) 0.89

Association between hearing loss and saccular dysfunction in older individuals. Otol Neurotol (2012) 0.86

Ocular VEMPs indicate repositioning of otoconia to the utricle after successful liberatory maneuvers in benign paroxysmal positioning vertigo. Acta Otolaryngol (2013) 0.86

Vestibular involvement in cognition: Visuospatial ability, attention, executive function, and memory. J Vestib Res (2015) 0.85

Association between saccular function and gait speed: data from the Baltimore Longitudinal Study of Aging. Otol Neurotol (2015) 0.83

Normative results of healthy older adults on standard clinical vestibular tests. Otol Neurotol (2014) 0.81

Smokeless Tobacco Use and the Risk of Head and Neck Cancer: Pooled Analysis of US Studies in the INHANCE Consortium. Am J Epidemiol (2016) 0.81

Evaluation of a bedside test of utricular function - the bucket test - in older individuals. Acta Otolaryngol (2014) 0.80

Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth. Sex Transm Dis (2015) 0.80

The Use of Fall Risk Increasing Drugs (FRIDs) in Patients With Dizziness Presenting to a Neurotology Clinic. Otol Neurotol (2015) 0.78

Human papillomavirus-16 associated adenocarcinoma NOS of base of tongue. Head Neck Pathol (2012) 0.77

Sex and age associations with vestibular schwannoma size and presenting symptoms. Otol Neurotol (2012) 0.77

Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients. Carcinogenesis (2016) 0.77

Vestibular Impairment in Dementia. Otol Neurotol (2016) 0.76

Age-Related Imbalance Is Associated With Slower Walking Speed: An Analysis From the National Health and Nutrition Examination Survey. J Geriatr Phys Ther (2016) 0.75

Compensatory Saccades Are Associated With Physical Performance in Older Adults: Data From the Baltimore Longitudinal Study of Aging. Otol Neurotol (2017) 0.75

The link between allergy and Menière's disease. Curr Opin Otolaryngol Head Neck Surg (2014) 0.75

Development and validation of a falls-grading scale. J Geriatr Phys Ther (2013) 0.75

Adaptation and Compensation of Vestibular Responses Following Superior Canal Dehiscence Surgery. Otol Neurotol (2016) 0.75

Risk factors for vagal palsy following cerebellopontine angle surgery. Otolaryngol Head Neck Surg (2012) 0.75

Imaging case of the month: Cystic lesions of the petrous apex: identification based on magnetic resonance imaging characteristics. Otol Neurotol (2012) 0.75

Association Between Saccule and Semicircular Canal Impairments and Cognitive Performance Among Vestibular Patients. Ear Hear (2019) 0.75

Vestibular dysfunction in Turner syndrome: a case report. Otol Neurotol (2014) 0.75

Prevalence, characteristics, and management of swallowing disorders following cerebellopontine angle surgery. Otolaryngol Head Neck Surg (2011) 0.75